M Zhang, Y Liang, D Yu, B Du, W Cheng… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Vaccines are proving to be highly effective in controlling hospitalization and deaths associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
C Schultheiß, E Willscher, L Paschold, C Gottschick… - Cell Reports …, 2022 - cell.com
Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …
Simple Summary The family of coronaviruses comprises a diverse set of strains and variants which cause diseases from the common cold to COVID-19. Moreover, they infect a wide …
The world is grappling with an unprecedented public health crisis COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2. Due to the high transmission/mortality rates …
Abnormal inflammatory mediator concentrations during SARS-CoV-2 infection may represent disease severity. We aimed to assess plasma inflammatory mediator …
H Li, X Li, Q Wu, X Wang, Z Qin, Y Wang, Y He… - Cell Death & …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) has gained prominence as a global pandemic. Studies have suggested that systemic alterations persist in a considerable …
B He, Z Huang, C Huang… - PROTEOMICS–Clinical …, 2022 - Wiley Online Library
In the context of precision medicine, disease treatment requires individualized strategies based on the underlying molecular characteristics to overcome therapeutic challenges …
K Nash, J Lai, K Sandhu, JS Chandan… - BMC Public Health, 2022 - Springer
Abstract Background Non-pharmaceutical interventions (NPIs), such as travel restrictions, social distancing and isolation policies, aimed at controlling the spread of COVID-19 may …
C Ortiz-Cartagena, L Fernández-García… - Microbiology …, 2022 - Am Soc Microbiol
At the end of 2019, a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused a pandemic that persists to date and has resulted in more than 6.2 …